SFRS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.561800E-01
Normal-vs-Stage2
4.297800E-01
Normal-vs-Stage3
1.131020E-01
Normal-vs-Stage4
6.849400E-01
Stage1-vs-Stage2
6.492600E-01
Stage1-vs-Stage3
9.554400E-02
Stage1-vs-Stage4
5.128600E-01
Stage2-vs-Stage3
6.327900E-02
Stage2-vs-Stage4
2.103400E-01
Stage3-vs-Stage4
5.811600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.103800E-02
Normal-vs-AfricanAmerican
2.821600E-01
Normal-vs-Asian
6.367600E-02
Caucasian-vs-AfricanAmerican
8.673600E-01
Caucasian-vs-Asian
2.757000E-01
AfricanAmerican-vs-Asian
3.610400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.037400E-01
Normal-vs-Female
8.030100E-02
Male-vs-Female
4.557600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.476800E-01
Normal-vs-Age(41-60Yrs)
5.300600E-01
Normal-vs-Age(61-80Yrs)
4.406200E-02
Normal-vs-Age(81-100Yrs)
1.156430E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.961600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.205200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.225000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.066270E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.316220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.783400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.897500E-02
Normal-vs-Daily Drinker
4.124300E-02
Normal-vs-Weekly Drinker
1.114450E-01
Normal-vs-Occasional Drinker
2.005000E-01
Normal-vs-Social Drinker
2.184600E-01
Non Drinker-vs-Daily Drinker
5.714600E-01
Non Drinker-vs-Weekly Drinker
7.060800E-01
Non Drinker-vs-Occasional Drinker
1.173200E-01
Non Drinker-vs-Social Drinker
1.097210E-01
Daily Drinker-vs-Weekly Drinker
4.312800E-01
Daily Drinker-vs-Occasional Drinker
6.139700E-02
Daily Drinker-vs-Social Drinker
5.956000E-02
Weekly Drinker-vs-Occasional Drinker
3.376800E-01
Weekly Drinker-vs-Social Drinker
3.064000E-01
Occasional Drinker-vs-Social Drinker
9.284200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.366000E-01
Normal-vs-Grade 2
5.709200E-01
Normal-vs-Grade 3
5.307400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.248000E-01
Grade 1-vs-Grade 3
1.232810E-01
Grade 1-vs-Grade 4
2.366000E-01
Grade 2-vs-Grade 3
2.235200E-01
Grade 2-vs-Grade 4
5.709200E-01
Grade 3-vs-Grade 4
5.307400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.624200E-02
Normal-vs-NonDiabetic
3.959800E-01
Diabetic-vs-NonDiabetic
3.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.906800E-01
Normal-vs-NoPancreatitis
3.859000E-01
Pancreatitis-vs-NoPancreatitis
9.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.112560E-01
Normal-vs-N1
4.266000E-01
N0-vs-N1
9.944600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.268600E-01
Normal-vs-TP53-NonMutant
1.605800E-01
TP53-Mutant-vs-TP53-NonMutant
2.754800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
